-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the Ministry of Commerce issued the "Guiding Opinions on Promoting the High-quality Development of the Pharmaceutical Circulation Industry During the "14th Five-Year Plan" Period" (hereinafter referred to as the "Opinions"), which clearly put forward the requirements for increasing the concentration of the industry
.
Among them, it is worth noting that the "Opinions" mentioned that by 2025, 5-10 specialized and diversified pharmaceutical retail chain enterprises with a value of more than 50 billion yuan should be cultivated.
The total market is over 65%, and the drug retail chain rate is close to 70%
.
Regarding the formulation of "retail chain rate close to 70%" in the "Opinions", industry analysts believe that using 561,000 pharmacies as the base number, the number of single pharmacies will be reduced to 168,300 in the next three years, compared with the current approximately The number of 250,000 homes may drop by nearly 80,000
.
This also means that a number of small and medium pharmacies will be eliminated or merged and reorganized at an accelerated pace in the future, and the market share of chain giants will further increase
.
It is understood that, in fact, it can be seen from the published performance of the listed chains in the first three quarters that in recent years, the major chain giants have been accelerating their efforts to increase their chain rate
.
For example, the number of stores in the four listed chains of Yixintang, Dashenlin, Laobai, and Yifeng Pharmacy are relatively close, and Yixintang and Laobai are in the same echelon, vying for the first name; and the total number of stores of Yifeng Pharmacy and Dashenlin is also close.
Crossed the threshold of 7000
.
The industry expects that with the continuous support of relevant policies and the continuous release of dividends from the out-of-hospital retail market in the future, chain pharmacies will continue to intensify mergers and acquisitions to further increase market share, and the industry market concentration will also accelerate
.
It is worth noting that, in this context, the life of single drugstores may become more and more difficult
.
In fact, on the whole, the dense store layout of chain pharmacies has already seriously affected the development of single stores.
In recent years, the impact of drug price reductions and large-scale purchases have been superimposed.
The passenger flow and profit of single stores have been declining.
The number of stores It is also constantly decreasing
.
Therefore, the industry predicts that under the huge transformation and upgrading pressure of the current increase in industry concentration, a large number of monomer pharmacies will be eliminated at an accelerated pace.
.
Then, in a market environment where the overall disadvantages outweigh the advantages, how can single pharmacies enhance their competitiveness and not be easily eliminated? In this regard, the industry has put forward several suggestions
.
One: Single pharmacies can choose to join chain pharmacies to obtain the assistance of sales channels, product purchases and corporate management, get the fundamental guarantee of survival, and seek long-term development capabilities
.
Two: Single pharmacies can build themselves into specialty pharmacies.
On the basis of good internal strength, they can rationally use their own advantages and find their own characteristics, so as to achieve long-term, stable and benign growth
.
Three: Single pharmacies need to continuously improve service quality, service level and capabilities, and capture the hearts of consumers through daily and characteristic services
.
For example, it provides value-added services such as home delivery of medicines, decocting medicines on behalf of customers, and regular disease and product training for consumers
.
Four: Individual pharmacies can also try to "connect to the Internet", get on the Internet Express, and explore new development models
.
In short, it is either to continue to expand, chain development, or transform and upgrade, or use strength or group together
.
In general, under policy encouragement and market development trends, the pharmacy industry is entering a stage of transformation and upgrading
.
With the continuous simplification, optimization and normalization of relevant policies for mergers and acquisitions and reorganization, chain pharmacies will become a trend
.
Affected by this, the number of single pharmacies will continue to decrease, and the pressure to survive will continue to increase
.
.
Among them, it is worth noting that the "Opinions" mentioned that by 2025, 5-10 specialized and diversified pharmaceutical retail chain enterprises with a value of more than 50 billion yuan should be cultivated.
The total market is over 65%, and the drug retail chain rate is close to 70%
.
Regarding the formulation of "retail chain rate close to 70%" in the "Opinions", industry analysts believe that using 561,000 pharmacies as the base number, the number of single pharmacies will be reduced to 168,300 in the next three years, compared with the current approximately The number of 250,000 homes may drop by nearly 80,000
.
This also means that a number of small and medium pharmacies will be eliminated or merged and reorganized at an accelerated pace in the future, and the market share of chain giants will further increase
.
It is understood that, in fact, it can be seen from the published performance of the listed chains in the first three quarters that in recent years, the major chain giants have been accelerating their efforts to increase their chain rate
.
For example, the number of stores in the four listed chains of Yixintang, Dashenlin, Laobai, and Yifeng Pharmacy are relatively close, and Yixintang and Laobai are in the same echelon, vying for the first name; and the total number of stores of Yifeng Pharmacy and Dashenlin is also close.
Crossed the threshold of 7000
.
The industry expects that with the continuous support of relevant policies and the continuous release of dividends from the out-of-hospital retail market in the future, chain pharmacies will continue to intensify mergers and acquisitions to further increase market share, and the industry market concentration will also accelerate
.
It is worth noting that, in this context, the life of single drugstores may become more and more difficult
.
In fact, on the whole, the dense store layout of chain pharmacies has already seriously affected the development of single stores.
In recent years, the impact of drug price reductions and large-scale purchases have been superimposed.
The passenger flow and profit of single stores have been declining.
The number of stores It is also constantly decreasing
.
Therefore, the industry predicts that under the huge transformation and upgrading pressure of the current increase in industry concentration, a large number of monomer pharmacies will be eliminated at an accelerated pace.
.
Then, in a market environment where the overall disadvantages outweigh the advantages, how can single pharmacies enhance their competitiveness and not be easily eliminated? In this regard, the industry has put forward several suggestions
.
One: Single pharmacies can choose to join chain pharmacies to obtain the assistance of sales channels, product purchases and corporate management, get the fundamental guarantee of survival, and seek long-term development capabilities
.
Two: Single pharmacies can build themselves into specialty pharmacies.
On the basis of good internal strength, they can rationally use their own advantages and find their own characteristics, so as to achieve long-term, stable and benign growth
.
Three: Single pharmacies need to continuously improve service quality, service level and capabilities, and capture the hearts of consumers through daily and characteristic services
.
For example, it provides value-added services such as home delivery of medicines, decocting medicines on behalf of customers, and regular disease and product training for consumers
.
Four: Individual pharmacies can also try to "connect to the Internet", get on the Internet Express, and explore new development models
.
In short, it is either to continue to expand, chain development, or transform and upgrade, or use strength or group together
.
In general, under policy encouragement and market development trends, the pharmacy industry is entering a stage of transformation and upgrading
.
With the continuous simplification, optimization and normalization of relevant policies for mergers and acquisitions and reorganization, chain pharmacies will become a trend
.
Affected by this, the number of single pharmacies will continue to decrease, and the pressure to survive will continue to increase
.
